Two people receive the identical injection, performed by the same hands, into the same anatomical target. One heals. One does not. That happens often enough that most patients who have been through it eventually assume they are the problem — that their body is somehow too broken to respond.
It is not luck, and it is not that you are too broken. The variable is your metabolic terrain, and almost nobody is checking it.
You are not a machine
Replace a belt on a car and the car runs. Every time. The part is the problem, the part is the solution, and the repair does not depend on the car’s willingness to cooperate.
You are not a machine. You are a living biological ecosystem, and if that ecosystem is in chaos, no injection on earth can force it to heal. The injection is not the repair — it is an instruction to repair. Whether the instruction gets carried out depends entirely on the state of the biology receiving it.
Injecting growth factors into a body in metabolic disarray is like building a house on a foundation that is sinking, and on fire. The construction crew is competent. The blueprint is sound. The site cannot support the work.
Survival mode cannot afford repair
Here is the mechanism underneath that image.
When your body is stuck in survival mode from insulin resistance and chronic inflammation, it cannot afford repair. Repair is expensive. Building tissue requires energy, raw material, and a signaling environment that permits construction. A body that is inflamed and mis-signaled is spending its budget on defense, and it will not fund construction while it believes it is under threat.
That state has a name: metainflammation — the chronic, metabolically driven inflammation that connects metabolic dysfunction to the tissue-level failures patients experience as pain.
And it is not a niche finding. Roughly 93% of chronic pain involves metabolic dysfunction. That number reframes what chronic pain actually is. If the overwhelming majority of chronic pain occurs in a body with disordered metabolism, then a treatment model that examines only the painful structure is examining the smaller part of the problem.
What standard care does with this
The standard response to metabolic dysfunction is a sentence: eat less, move more.
That is a judgment dressed up as medicine. It is not a diagnosis. It identifies no mechanism, measures no marker, and gives you nothing you can act on with precision. Told to a person whose insulin signaling is disordered and whose inflammatory load is elevated, it functions primarily as an assignment of blame.
If you have been dismissed or gaslit — told your pain is disproportionate, your body is too far gone, your expectations are unrealistic — the more likely explanation is not that you are too broken. It is that you have never been properly evaluated. Those are very different conclusions, and only one of them leaves you with something to do.
This is a critique of a model, not of the clinicians inside it. A system organized around procedures and fifteen-minute visits does not have room to audit a metabolic ecosystem.
Auditing the whole system
At Regen.MD the evaluation looks at the terrain before it looks at the needle. That means examining:
Insulin signaling. Whether your cells are still responding normally to the hormone that governs fuel access — the central lever in whether your body is in a building state or a defending one.
Mitochondrial function. The cellular machinery that generates the energy every repair process draws on. Repair without energy is an instruction that cannot be executed.
The gut. A source of inflammatory signaling that reaches far beyond the abdomen.
Your unified neuro-metabolic architecture. Nervous system and metabolism as one interacting system rather than two specialties.
Fix the terrain first, and two things happen. Pain often quiets on its own — because a substantial part of it was being generated by the inflammatory and metabolic state rather than by structure alone. And the injections that failed elsewhere finally work, because the instruction is now being delivered to a body capable of carrying it out.
That sequence is the whole argument. Not different needles. A different order of operations.
Frequently asked questions
Why would the same injection work for someone else and not for me?
Because an injection is an instruction, and the response depends on the biological state receiving it. A body in survival mode from insulin resistance and chronic inflammation cannot afford the repair the injection is asking for. The difference between responders and non-responders is frequently terrain, not technique.
Is metabolic dysfunction really relevant if my pain is clearly in one joint?
Roughly 93% of chronic pain involves metabolic dysfunction, which means localized pain and systemic disorder coexist far more often than the specialty structure implies. A local problem in a systemically compromised body is still a systemically compromised body, and that is what determines whether the local tissue can heal.
Should I stop a treatment my current physician recommended?
Never stop or change a prescribed treatment on your own. Bring these questions to the physician who knows your case, or seek a formal second evaluation. Nothing here is a directive to discontinue care.
Does fixing the terrain mean I will not need an injection at all?
Sometimes pain quiets on its own once the terrain is corrected. Sometimes the terrain work is what makes an injection finally effective. Which of those applies to you is a clinical question that depends on what the evaluation finds, and individual results vary.
Key takeaways
- You are a biological ecosystem, not a machine — an injection is an instruction, not a guaranteed repair.
- Insulin resistance and chronic inflammation keep the body in survival mode, where it cannot afford to fund repair.
- Metainflammation is the mechanism linking metabolic dysfunction to tissue that will not heal.
- Roughly 93% of chronic pain involves metabolic dysfunction, so terrain is the rule rather than the exception.
- Auditing insulin signaling, mitochondrial function, the gut, and neuro-metabolic architecture comes before the needle, not after it.
Medically reviewed by Gurpreet Singh Padda, MD, MBA, MHP — Board Certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.
This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary, and not every patient is a candidate for the therapies described. Do not start, stop, or change any treatment without consulting your physician. Orthobiologic therapies are not FDA-approved for these indications and are provided as part of physician-directed care.
Find out what is actually driving your pain
Regen.MD begins with a physician-led Clinical Evaluation — a review of your history, imaging, and metabolic data, and a written terrain roadmap. Evaluation is contingent upon review of your data.
Questions? Call (314) 668-1525 or text (314) 886-5902.

Leave a Reply